Intestinal inflammation, ileal structure and function in HIV

被引:62
作者
Bjarnason, I
Sharpstone, DR
Francis, N
Marker, A
Taylor, C
Barrett, M
Macpherson, A
Baldwin, C
Menzies, IS
Crane, RC
Smith, T
Pozniak, A
Gazzard, BG
机构
[1] UNIV LONDON KINGS COLL,SCH MED & DENT,DEPT MED,LONDON SE5 9PJ,ENGLAND
[2] UNIV LONDON KINGS COLL,SCH MED & DENT,DEPT HISTOPATHOL,LONDON SE5 9PJ,ENGLAND
[3] UNIV LONDON KINGS COLL,SCH MED & DENT,DEPT GENITOURINARY MED,LONDON SE5 9PJ,ENGLAND
[4] CHELSEA & WESTMINSTER HOSP,DEPT GASTROENTEROL,LONDON,ENGLAND
[5] CHELSEA & WESTMINSTER HOSP,DEPT HISTOPATHOL,LONDON,ENGLAND
[6] CHELSEA & WESTMINSTER HOSP,DEPT GENITOURINARY MED & HIV,LONDON,ENGLAND
关键词
intestinal function; intestinal inflammation; inflammatory bowel disease;
D O I
10.1097/00002030-199610000-00011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: This study examines small intestinal absorption-permeability, intestinal inflammation and ileal structure and function in HIV-positive male homosexuals. Methods: Thirty HIV-seropositive male homosexuals at various stages of disease underwent intestinal absorption-permeability and (111)indium leukocyte studies (for quantification of intestinal inflammation). Twenty-six men with AIDS had a dual radioisotopic ileal function test (whole body retention of tauro 23-[Se-75]-selena 25-homocholic acid and (58)cobalt-labelled cyanocobalamine), and 17 underwent ileocolonoscopy with terminal ileal biopsy. Results: Well, HIV-infected, subjects had normal intestinal absorption-permeability, but both functions were impaired upon the development of AIDS. The median faecal excretion of (111)indium in well patients (0.66%) did not differ significantly (P > 0.5) from controls (0.46%), but subjects with AIDS who were well or who had diarrhoea had significant (P < 0.005) intestinal inflammation (1.33% and 2.18%, respectively). The median 7-day retention of tauro 23-[Se-75]-selena 25-homocholic acid in well patients with AIDS (38.9%) did not differ significantly (P > 0.2) from controls (39.3%), whereas the absorption of (58)cobalt-labelled cyanocobalamine was significantly (P < 0.05) lower than controls (32.1% and 59.4%). Patients with AIDS-diarrhoea had significant (P < 0.001) malabsorption of both the bile acid (7.7%) and vitamin B-12 (8.9%) which was more severe than in Crohn's ileitis (14.2% and 30.3%, respectively). Morphometric analyses of ileal biopsies were unremarkable in AIDS. Conclusions: These studies demonstrate a low-grade enteropathy in patients with AIDS, severe ileal malabsorption in patients with AIDS diarrhoea and relatively minor ileal morphologic changes. Malabsorption of bile acids may play a pathogenic role in patients with AIDS and diarrhoea.
引用
收藏
页码:1385 / 1391
页数:7
相关论文
共 44 条
[1]   AUTONOMIC DENERVATION IN JEJUNAL MUCOSA OF HOMOSEXUAL MEN INFECTED WITH HIV [J].
BATMAN, PA ;
MILLER, ARO ;
SEDGWICK, PM ;
GRIFFIN, GE .
AIDS, 1991, 5 (10) :1247-1252
[2]   ASSOCIATION OF GASTRIC HYPOACIDITY WITH OPPORTUNISTIC ENTERIC INFECTIONS IN PATIENTS WITH AIDS [J].
BELITSOS, PC ;
GREENSON, JK ;
YARDLEY, JH ;
SISLER, JR ;
BARTLETT, JG .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02) :277-284
[3]  
BEST WR, 1979, GASTROENTEROLOGY, V77, P843
[4]   NONSTEROIDAL ANTIINFLAMMATORY DRUG-INDUCED INTESTINAL INFLAMMATION IN HUMANS [J].
BJARNASON, I ;
ZANELLI, G ;
SMITH, T ;
PROUSE, P ;
WILLIAMS, P ;
SMETHURST, P ;
DELACEY, G ;
GUMPEL, MJ ;
LEVI, AJ .
GASTROENTEROLOGY, 1987, 93 (03) :480-489
[5]   INTESTINAL PERMEABILITY - AN OVERVIEW [J].
BJARNASON, I ;
MACPHERSON, A ;
HOLLANDER, D .
GASTROENTEROLOGY, 1995, 108 (05) :1566-1581
[6]   METRONIDAZOLE REDUCES INTESTINAL INFLAMMATION AND BLOOD-LOSS IN NONSTEROIDAL ANTIINFLAMMATORY DRUG-INDUCED ENTEROPATHY [J].
BJARNASON, I ;
HAYLLAR, J ;
SMETHURST, P ;
PRICE, A ;
GUMPEL, MJ .
GUT, 1992, 33 (09) :1204-1208
[7]  
BJARNASON I, 1994, INFLAMM BOWEL DIS, P53
[8]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[9]   NATURAL-HISTORY AND PROGNOSIS OF DIARRHEA OF UNKNOWN CAUSE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) [J].
BLANSHARD, C ;
GAZZARD, BG .
GUT, 1995, 36 (02) :283-286
[10]  
BURKES RL, 1987, EUR J HAEMATOL, V38, P141